LD-2 disclosure · 1st Quarter - Termination
TELIX PHARMACEUTICALS, INC.
via HALL, RENDER, KILLIAN, HEATH & LYMAN, P.C.
Coverage · No income or expenses were reported on this filing.
Client
- Name
- TELIX PHARMACEUTICALS, INC.
- Description
- Pharmaceutical Company
- Location
- Indiana · United States of America
Registrant
- Firm
- HALL, RENDER, KILLIAN, HEATH & LYMAN, P.C.
- Description
- Law Firm
- Location
- Indianapolis, Indiana, United States of America
Lobbying activities
1 issueMedicare/Medicaid
FIND Act of 2023
Lobbyistsmr JOHN FRANCIS WILLIAMS iii · ABIGAIL KAERICHER
Covered position (mr JOHN FRANCIS WILLIAMS iii): Press Secretary, House Committee on Government Reform and Oversight; Press Secretary, Rep. Dan Burton.
TargetedSENATE · HOUSE OF REPRESENTATIVES